|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
The Pharmacoeconomics of Venlafaxine in Depression
Author(s)Thomas J. Morrow, MD
Advertisement
Articles in this issue
over 24 years ago
Participating Facultyover 24 years ago
IntroductionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5
